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Expanded WartsThe Fat-Hippo signaling pathway plays an important role in the regulation of normal organ growth during
development, and in pathological growth during cancer. Fat-Hippo signaling controls growth through a
transcriptional co-activator protein, Yorkie. A Fat-Hippo pathway has been described in which Yorkie is
repressed by phosphorylation, mediated directly by the kinase Warts and indirectly by upstream tumor
suppressors that promote Warts kinase activity. We present here evidence for an alternate pathway in which
Yorkie activity is repressed by direct physical association with three other pathway components: Expanded,
Hippo, and Warts. Each of these Yorkie repressors contains one or more PPXY sequence motifs, and
associates with Yorkie via binding of these PPXY motifs to WW domains of Yorkie. This direct binding
inhibits Yorkie activity independently from effects on Yorkie phosphorylation, and does so both in vivo and
in cultured cell assays. These results emphasize the importance of the relative levels of Yorkie and its
upstream tumor suppressors to Yorkie regulation, and suggest a dual repression model, in which upstream
tumor suppressors can regulate Yorkie activity both by promoting Yorkie phosphorylation and by direct
binding.
© 2009 Elsevier Inc. All rights reserved.Introduction
The Fat-Hippo signaling pathway plays an essential role in the
regulation of organ growth from Drosophila to mammals (reviewed in
Reddy and Irvine, 2008). Many of the components of this pathway
were ﬁrst identiﬁed as tumor suppressor genes, and the importance
of this pathway in diverse cancers has been increasingly recognized.
Fat-Hippo signaling controls growth through the regulation of
transcription. The critical mediator of its effects on transcription is
a transcriptional co-activator protein, called Yorkie (Yki) in Droso-
phila and YAP mammals (Huang et al., 2005). Yki acts as an oncogene,
and in conjunction with the DNA-binding protein Scalloped (Sd),
promotes the expression of genes that accelerate growth and cell
cycle progression, whilst inhibiting apoptosis (reviewed in Reddy and
Irvine, 2008).
Most of the known upstream components of Fat-Hippo signaling
function as tumor suppressors, and normally inhibit Yki activity. This
inhibition is effected most directly by Warts (Wts), a kinase that
phosphorylates Yki (Huang et al., 2005). Phosphorylation of Yki or
YAP inhibits Yki activity by promoting its retention in the cytoplasm
(Dong et al., 2007; Hao et al., 2008; Oh and Irvine, 2008; Zhang et al.,
2008; Zhao et al., 2007). Wts in turn is regulated by several upstream
tumor suppressors that inﬂuence its levels and activity, including
Mats, which acts as an essential co-factor forWts, Hippo (Hpo), which
is a kinase that phosphorylates Mats andWarts, Salvador, which bindsrvine).
ll rights reserved.to Wts and Hpo, Expanded (Ex) and Merlin, two FERM domain
proteins that promote Hpo activity, and Fat, a protocadherin that
inﬂuences the levels or localization of Wts and Ex via the
unconventional myosin Dachs (reviewed in Reddy and Irvine, 2008).
Structure–function studies of Yki have led to the identiﬁcation of
several motifs important for its activity. A critical Wts phosphoryla-
tion site is Ser168, phosphorylation of which creates a binding site for
14-3-3 proteins (Dong et al., 2007; Oh and Irvine, 2008; Zhang et al.,
2008; Zhao et al., 2007). This contributes to the retention of
phosphorylated Yki in the cytoplasm, as mutation of Ser168 to Ala
hyperactivates Yki and increases its nuclear localization. Yki also has
two additional Wts phosphorylation sites, at Ser111 and Ser250, each
of which makes additional contributions to the repression of Yki
activity (Oh and Irvine, 2009). Sd binds to a conserved region in the
amino terminus of Yki (Goulev et al., 2008;Wu et al., 2008; Zhang et al.,
2008). In addition, Yki has two WW domains, which are 35–40 amino
acid protein interaction domains that include two Trp residues (Macias
et al., 2002). The WW domains of Yki were ﬁrst identiﬁed for their role
in binding to Wts, which suggested that they might promote Yki
phosphorylation (Huang et al., 2005). However, subsequent studies
have shown that the WW domains are not required for Yki
phosphorylation (Oh and Irvine, 2008, 2009). More recently, we and
others have determined that the WW domains positively inﬂuence
Yki/YAP activity, presumably because they interact with co-factors that
are required for transcriptional activation by Yki (Oh and Irvine, 2009;
Wu et al., 2008; Zhao et al., 2009). In this work, we identify an
additional activity of the WW domains in repression of Yki, through a
mechanism that does not depend on the phosphorylation of Yki byWts.
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was suggested by characterization of a mutant form of Yki (Yki:
V5S111A,S168A,S250A, henceforth abbreviated as Yki:V53SA) in which all
three Wts phosphorylation sites are mutant (Oh and Irvine, 2009).
Expression of Yki:V53SA results in dramatic overgrowth phenotypes,
whereas expression of a wild-type form of Yki:V5 at the same level
results in no apparent phenotype, consistent with the conclusion that
phosphorylation of Yki by Wts represses Yki activity. Yki:V53SA was
also resistant to expression of upstream tumor suppressors implicated
in promoting Yki phosphorylation, because some overgrowth occurs
even when Yki:V53SA is co-expressed with Wts, Hpo, and Ex. However,
Wts, Hpo, and Ex did have an effect on Yki:V53SA, in that they could
reduce its nuclear localization, even though they could not affect its
phosphorylation. The discovery of this phosphorylation-independent
repression of Yki nuclear localization by upstream tumor suppressors
prompted further explorations of its mechanism and signiﬁcance.
Our results identify a phosphorylation-independent mechanism by
which upstream tumor suppressors, including Ex, Wts, and Hpo, can
repress Yki activity. This alternate mechanism involves interactions
between the WW domains of Yki and PPXY sequence motifs on its
binding partners. Recently, Badouel et al (2009) described the results
of studies in which they identiﬁed an ability of Ex to repress Yki
through a mechanism that depends on the PPXY motifs of Ex. As
discussed below, our results are consistent with this study in that we
also identify a phosphorylation-independent mechanism by which Ex
can repress Yki, but differ in our additional identiﬁcation of phosphor-
ylation-independent activities ofWts andHpo, and in our assessment of
the respective contributions of different mechanisms of Yki repression.
Materials and methods
Fly stocks
UAS-yki:V5 lines employed were site-speciﬁc insertions in the
attP2 site at 68A (UAS-yki:V5[attP-68A], or mutant variants) (Oh and
Irvine, 2009). For hpo, wts, and ex expression we used UAS-ex[ex-3]
(Boedigheimer et al., 1997), UAS-Myc:wts.2 (Jia et al., 2003), and UAS-
hpo[dMst.3] (Jia et al., 2003). For ectopic expression clones, y w hs-FLP
[122]; ActNy+NGal4 (AyGal4) or y w hs-FLP[122]; ActNy+NGal4 UAS-GFP
(AyGal4-GFP) were crossed to UAS-yki:V5[attP-68A] (or mutant iso-
forms). For co-expressionwith hpo,wts, and ex in clones, AyGal4 UAS-ex
was crossed to y w hs-FLP[122]; UAS-Myc:wts.2/CyO,GFP; UAS-yki:V5
UAS-hpo[dMst.3]/TM6b. Ectopic expression ofUAS-yki:V5 isoforms,with
or without UAS-hpo, UAS-wts, and UAS-ex was induced under GMR-
Gal4 control in crosses of GMR-Gal4 or GMR-Gal4; UAS-ex/TM6b to
y w hs-FLP[122]; UAS-Myc:wts.2/CyO,GFP; UAS-yki3SA:V5/TM6b or y w
hs-FLP[122]; UAS-Myc:wts.2/CyO,GFP; UAS-yki3SA:V5 UAS-hpo[dMst.3]/
TM6b. yki mutant clones were generated using FLP-FRT-mediated
recombination with w; ykiB5 FRT42D/CyO-GFP and y w hs-FLP;
FRT42D Ubi-GFP/CyO-GFP. wts mutant clones were generated using
y w hs-FLP tub-Gal4 UAS-GFP; UAS-y+/CyO; FRT82B tub-Gal80/TM6b,
y w hs-FLP; If/CyO; FRT82B wtsX1/TM6b and y w hs-FLP; If/CyO; UAS-Ex
FRT82BwtsX1/TM6b. The site-speciﬁc insertionsUAS-Myc:wts[attP-25C7]
and UAS-Myc:wtsK743A[attP-25C7] (kinase dead) lines were created by
inserting KpnI–XbaI fragments from UAS-Myc:Wts plasmids into
pUAST-attB; the resulting plasmids were then inserted into the
attP40 site at 25C7 by phiC31-mediated integration (Genetic Services).
Unless otherwise noted, all ﬂies were cultured at 25 °C.
Histology and imaging
Imaginal discs were ﬁxed and stained as described previously (Cho
and Irvine, 2004), using as primary antibodies rabbit anti-Yki
(1:4000)(Oh and Irvine, 2008), mouse anti-V5 (1:400, Invitrogen),
mouse anti-Diap1 (1: 600, gift from B. Hay) and guinea pig anti-Ex
(1:2000, gift from R. Fehon) mouse anti-Myc (1:200, Babco) and goatanti-β-gal (1:1000, Biogenesis). Fluorescent stains were captured on a
Leica TCS SP5 confocal microscope. For quantitative analysis of Yki
localization in wing imaginal disc cells, ratios of the average
ﬂuorescence intensity in the nucleus and cytoplasm of 30 cells were
measured using NIH Image J.
Plasmid constructs
Mutations in the ﬁve PPXY motifs of Wts (Y286A, Y304A, Y410A,
Y463A, Y550A), the PPXY motif of Hpo (Y591A) andWts-KD (K743A)
(kinase-dead) were introduced by primer-mediated site-directed
mutagenesis using QuikChange Multi Site-Directed Mutagenesis Kit
(Stratagene) according to the manufacturer’s instructions. Flag-
tagged Hpo, Myc-tagged Wts and HA-tagged Ex UAS expression
plasmids have been described previously (Hamaratoglu et al., 2006;
Jia et al., 2003). For some experiments these genes were cloned into
pAC5.1 for actin promoter regulated expression, pAC5.1-V5:Wts has
been described previously (Huang et al., 2005). pAC5.1-Gal4-DBD:
Yki:V5 has been described previously, pAC5.1-Gal4-DBD:Yki:HA was
created by exchanging a BamHI fragment from pAC5.1-yki:HA (Huang
et al., 2005) into pAC5.1-Gal4-DBD:Yki:V5.
S2 cell assays and co-immunoprecipitation
S2 cells were cultured with Schneider’s Drosophila medium
(Invitrogen) and 10% FBS (Sigma). For co-immunoprecipitations,
transient transfections were performed with equal amounts of DNA
(0.5 μg per construct) using Cellfectin (Invitrogen) in 6 well plates
according to the manufacturer’s protocol, using plasmids pAW-Gal4
(S.Blair), pAct-GFP:V5-His (Cho et al., 2006), Yki:V5 isoforms, pUAS-
Myc:Wts, pUAS-Flag:dMST (Jia et al., 2003), pAct-Ex:HA (Hamaratoglu
et al., 2006), pAC5.1-3xFLAG:Hpo, and pAC5.1-3xFLAG:HpoPPXA.
Co-immunoprecipitation assays were performed according to pub-
lished protocols (Chen et al., 2003). In brief, cells were harvested 48 h
later in RIPA lysis buffer (50 mM Tris–HCl, pH 7.5; 150 mM NaCl; 1%
NP40; 0.5% Sodium deoxycholate; 0.1% SDS; 1 mM EDTA) supple-
mented with protease inhibitor cocktail (Roche) and phosphatase
inhibitor cocktail (Calbiochem). Cell lysates (500 μg for each sample)
were incubated with 10 μl Anti-V5 or anti-FLAG beads (Sigma) at 4 °C
for 2 h followed by ﬁve washes in RIPA buffer. Beads were then boiled
in Laemmli sample buffer at 100 °C for ﬁve minutes and loaded onto
SDS-PAGE gels. Western blotted proteins were visualized using: rabbit
Anti-Myc (1:2000, Santa Cruz), rabbit anti-Wts, rabbit anti-Yki
(1:4000), rabbit anti-YkiS168P (gift of D. Pan), rabbit anti-Hpo
(1:2000, gift of N. Tapon), mouse anti-V5 (1:5000, Invitrogen), IRdye
800 conjugated anti-Flag (1:100000, rabbit), IR dye 800 conjugated
anti-HA (1:100000, rabbit) (Rockland), IR dye 800 conjugated anti-
rabbit (goat, 1:10000), IR dye 680 conjugated anti-mouse (goat,
1:10000) (Odyssey). Blots were analyzed using the Odyssey Infrared
Imaging system (Licor biosciences). Phos-tag gels (FMS Laboratory)
were prepared as described previously (Oh and Irvine, 2008).
Luciferase reporter assays were performed using the Dual
Luciferase Assay System (Promega) according to the manufacturer’s
instructions. S2 cells were transfected in triplicate with pUAST-
Luciferase (10 ng) and copia-renilla luciferase (0.2 ng) reporters (Lum
et al., 2003) in 24-well plates together with Gal4DB-Yki constructs
(100 ng) and upstream tumor suppressors (Hpo, Wts and/or Ex,
100 ng each, or 500 ng for a ﬁve fold increase) in a pAc5.1 vectors
(Invitrogen) and incubated for 48 h after transfection.
Results
Repression of unphosphorylatable Yki by upstream tumor suppressors
Clones of cells in which Wts, Hpo, and Ex are over-expressed
together with Yki:V53SA generally overgrow compared to control
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This is most evident within the wing pouch, in which clones of cells
co-expressing Yki:V53SA together with Hpo, Wts and Ex can be smallFig. 1. Phosphorylation-independent repression of Yki. (A–C) Horizontal (upper left) and v
V5 (wild-type control) or Yki:V53SA (activated Yki), identiﬁed by elevated Yki (red), and w
UAS-Myc:wts.2 ;UAS-yki:V53SA UAS-ex[ex-3]/UAS-hpo[dMst.3]. In the presence of elevated
(arrows). (C) actNy+NGal4 UAS-yki:V5. (D–L) Eye discs expressing Yki:V5 (UAS-yki:V5) or
with nuclei labeled by DAPI (cyan). (E) Expression of Yki:V53SA results in extensive overgr
UAS-Myc:wts.2 or UAS-hpo[dMst.3], or combinations thereof, with Yki:V53SA, as indicated. (
nuclear localization, using same genotypes as in E–L.and appear apoptotic, as evidenced by the small, fragmented nuclei
that appear basal to the disc epithelium (Fig. 1B). There also appeared
to be a tendency of Yki:V53SA clones to overgrow to a lesser extent inertical (bottom and right) sections of wing discs with ﬂip-out clones expressing Yki:
ith nuclei labeled by DAPI (cyan). (A) actNy+NGal4; UAS-yki:V53SA. (B) actNy+NGal4;
Wts, Hpo, and Ex, Yki:V53SA-expressing cells become apoptotic and drop basally
Yki:V53SA (UAS-yki:V53SA) under GMR-Gal4 control, stained for elevated Yki (red), and
owth, which is mostly taken up in folds of tissue. (F–L) Co-expression of UAS-ex[ex-3],
M–T) Close-ups of Yki:V53SA expression in eye discs under GMR-Gal4 control to show
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Ex, but because this effect was hard to quantify relative to the normal
variations in clone size, we turned to a system in which transgenes
would be expressed in constant regions.
This was achieved by expressing Yki:V53SA in eye discs under
GMR-Gal4 control, in the presence or absence of Wts, Hpo, and Ex.
GMR-Gal4 drives expression in the posterior of the third instar eye
disc, behind the morphogenetic furrow. Expression of UAS-Yki:V53SA
transgenes using GMR-Gal4 results in overgrowth of the eye disc
(Fig. 1E), and ultimately of the adult eye (Oh and Irvine, 2009),
which is mostly taken up in extensive folds of tissue. This
overgrowth and folding is largely suppressed by co-expression of
Hpo, Wts and Ex (Fig. 1L). Moreover, co-expression with Hpo, Wts
and Ex reduces nuclear accumulation of Yki3SA in the eye (Fig. 1T).
We also examined all of the possible single and double combinations
of Hpo, Wts and Ex co-expression with Yki3SA (Fig. 1). The repression
of Yki3SA-mediated overgrowth was most effective in the presence of
all three upstream tumor suppressors, although addition of Hpo and
Wts, or Hpo and Ex also had obvious growth inhibitory effects
(Figs. 1I-L), and an effect on nuclear localization could be detected
for all of the pair-wise combinations (Figs. 1Q-S). These observations
conﬁrm that there is a phosphorylation-independent mechanism by
which upstream tumor suppressors can inhibit Yki activity and
reduce its nuclear localization in vivo.
Binding of Yki to Hpo, Wts and Ex
Yki was ﬁrst identiﬁed through binding to Wts in a two-hybrid
screen, mediated by WW domain–PPXY motif interactions (Huang
et al., 2005). Yki has twoWW domains, and Wts has ﬁve PPXY motifs
(Fig. 2A). Interestingly, we found one PPXY motif in Hpo and three in
Ex, raising the possibility that Yki might also bind to them (Fig. 2A).
Indeed, when Hpo or Ex were co-expressed with Yki in cultured cells,
they could be co-precipitated with Yki, and their association was
abolished (Ex), or reduced (Hpo) by mutation of the WW domains
(Fig. 2B). When all four proteins were co-transfected together into S2
cells, Yki was partitioned among them, as it could be co-precipitated
with Wts, Ex, and Hpo (Fig. 2C). Examination of the Yki3SA mutant
established that this association does not depend on the Wts
phosphorylation sites of Yki (Figs. 2B, C). As the WW domains are
not required for phosphorylation of Yki by Wts (Oh and Irvine, 2008,
2009), the functional signiﬁcance of Yki–Wts binding was unknown.
The observations that Hpo, Wts and Ex can effect a phosphorylation-
independent repression of Yki in vivo, and that these proteins can all
bind directly to Yki, suggest that this binding mediates phosphory-
lation-independent repression.
The ability of Yki to bind to Ex was also recently identiﬁed by
Badouel et al (2009), but binding of Yki to Hpo has not been described
previously. Available antibodies against endogenous proteins did not
work well enough for us to detect a convincing signal above
background in co-immunoprecipitation experiments. However, co-
immunoprecipitation of endogenous Yki could be detected when
exogenous FLAG:Hpo was precipitated from S2 cells, and co-
immunoprecipitation of endogenous Hpo could be detected when
exogenous Yki:V5 was precipitated from S2 cells (Fig. 2E). Moreover,
mutation of the PPXY motif in Hpo (Y591A) abolished detectable
binding to Yki, but did not affect binding to Wts (Fig. 2F). These
observations suggest that Hpo and Yki can interact directly in vivo
through their PPXY and WW domains.
Phosphorylation-independent repression of Yki in S2 cells
Yki's activity as a transcriptional co-activator can be visualized by
measuring the activity of a Yki-Gal4 DNA binding domain fusion
(Gal4-DB:Yki) on a Gal4-responsive luciferase reporter (Huang et al.,
2005). To investigate phosphorylation-independent repression usingthis transcriptional assay, Gal4-DB:Yki or Gal4-DB:Yki3SA were co-
transfected with different combinations of upstream tumor suppres-
sors into S2 cells. Gal4-DB:Yki3SA exhibited greater transcriptional
activity than Gal4-DB:Yki under a range of conditions (Fig. 3A).
Moreover, individual expression of Ex, Wts and Hpo on their own at
moderate doses (i.e., using identical plasmid vectors and equal
amounts of DNA for Gal4-DB:Yki and each of these repressors)
partially repressed Gal4-DB:Yki-mediated transcriptional activation,
but failed to repress Gal4-DB:Yki3SA-mediated transcriptional activa-
tion, consistent with the importance of Yki phosphorylation in Yki
repression.
However, when multiple upstream tumor suppressors were
combined (i.e. Hpo, Wts and Ex) then Gal4-DB:Yki3SA was also
repressed (Fig. 3A), consistent with the repression of Yki3SA observed
in vivo. In control experiments, transcription mediated by Gal4-DB
alone, or by full length Gal4, was not affected (Fig. 3 and data not
shown). To investigate whether phosphorylation-independent re-
pression requires combinations of upstream tumor suppressors, or
might instead be achieved by increasing the quantity of a single gene,
we examined the ability of upstream tumor suppressors to repress
Gal4-DB:Yki3SA when co-transfected in ﬁve-fold greater amounts.
Under these conditions, Wts or Ex strongly repressed both Gal4-DB:
Yki and Gal4-DB:Yki3SA, whereas Hpo strongly repressed Gal4-DB:Yki
but not Gal4-DB:Yki3SA (Fig. 3A). In order to conﬁrm that the levels of
Ex or Wts need for phosphorylation-independent repression are only
a few fold greater than the levels of Yki, we also constructed and
characterized transgenes with the same epitope tags (Gal4-DBD:
Yki3SA:HA and Ex:HA, Gal4-DBD:Yki3SA:V5 and V5:Wts), such that
their levels could be directly compared by Western blotting.
Phosphorylation-independent repression was also observed using
these constructs, and, levels of Ex or Wts were only modestly greater
than levels of Yki (Fig. 3D).
To investigate requirements for Wts kinase activity in Yki
repression, we assayed a kinase dead mutant isoform (WtsKD)(Wei
et al., 2007). At moderate levels, WtsKD had no effect on either Gal4-
DB:Yki or Gal4-DB:Yki3SA, but at ﬁve-fold higher levels, WtsKD
repressed their activity (Figs. 3A, B). Wild-type Wts and WtsKD were
expressed at similar levels in S2 cells (Fig. 2D). However, when we
compared the expression of wild-type Wts and WtsKD in imaginal
discs, the levels of WtsKD were substantially lower (Supplementary
Figure S1). Because the wts expression transgenes in this experiment
were inserted at the same cytological location using phiC31 mediated
integration (Groth et al., 2004), it appears that inactive Wts is less
stable in disc cells, at least when over-expressed. Expression of WtsKD
under GMR-Gal4 or en-Gal4 control did not result in evident
phenotypes, but as the levels of expression are so low, the signiﬁcance
of this negative result is unclear.
The role of the WW domains in this repression cannot be directly
assessed, because they are also positively required for Yki transcrip-
tional activity (Oh and Irvine, 2009). However, when the ﬁve PPXY
motifs of Wts were mutated by changing the Tyr residues to Ala
(Wts5PPxA), the ability of Wts to effect phosphorylation independent
repression was lost (Fig. 3B). As expected, Wts5PPxA also failed to bind
to Yki in co-IP experiments, but still promoted Yki phosphorylation
(Fig. 2D). Using a similar assay, Badouel et al (2009) observed that
mutation of the PPXY motifs of Ex impaired its ability to repress Yki.
Altogether, these results conﬁrm the existence of phosphorylation-
independent repression of Yki transcriptional activity, and show that
it is effected by upstream tumor suppressors with PPXY motifs.
Inﬂuence of WW domain-PPXY interactions on Yki localization
Endogenous Yki is broadly distributed throughout the cytoplasm
(Figs. 4C, D)(Oh and Irvine, 2008), whereas Ex is localized to the
subapical membrane (Boedigheimer et al., 1997), so only a small
fraction of endogenous Yki could normally be associated with Ex
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Fig. 3. Phosphorylation-independent repression of Yki-mediated transcription. Expression from a UAS-luciferase reporter is indicated by luciferase activity in lysates of S2 cells
transfected to express wild-type (red) or 3SA mutant (green) Gal4-DBD:Yki:V5 fusions (Yki) (or a control Gal4-DBD protein, blue). In A, B, where indicated, Yki transgenes were co-
expressed with Flag:Hpo (H), Ex:HA (E), Myc:Wts (W), or Myc:WtsKD or Myc:Wts5xPPxA mutants, using equal amounts of DNA, or, where indicated (5×), a ﬁve-fold excess of DNA.
Histograms depict the average values from triplicate experiments; error bars indicate standard deviation. The results depicted in A and B are from separate experiments. (C)Western
blot on lysates from samples in B, showing similar expression of Wts. (D) Upper panel shows luciferase activity, lower panel shows Western blot on the same cell lysates. The ﬁrst
three experimental (Yki) samples employed HA-tagged Ex and Gal4-DBD:Yki, and the last three employed V5-tagged Wts and Gal4-DBD:Yki, as indicated. The proteins are
distinguished on the Western blots by their mobilities, Gal4-DBD:Yki runs as a doublet.
Fig. 2. Binding of Hpo, Wts, and Ex to Yki. (A) Schematic structures of Ex, Wts, Hpo, and Yki, depicting locations of FERM domain, PPXY motifs, kinase domains, WW domains, Sd
binding region of Yki (NH) and Wts phosphorylation sites on Yki (P). (B–F) Co-immunoprecipitation experiments on proteins expressed in S2 cells. Upper panels (input) show
Western blots on lysates, lower panels (IP) showWestern blots on material precipitated on anti-V5 or anti-FLAG beads, as indicated. (B) Co-precipitation of tagged Yki and Ex (left)
or Yki and Hpo (right) is eliminated or reduced by mutation of the WW domains (-WW) but is not affected by mutation of the Yki phosphorylation sites (3SA). 3SA-WW is a Yki
isoform that includes bothWWdomain and phosphorylation site mutations. (C) Co-precipitation of tagged Hpo,Wts, and Exwith Yki. When all four proteins aremixed together, Yki
co-precipitates Hpo, Wts, or Ex, and this association is eliminated or reduced by mutation of the WW domains (-WW) but not by mutation of Yki phosphorylation sites (3SA). (D)
Binding between Yki andWts requires the PPXYmotifs, but not the kinase activity ofWts (Wts-KD).Wts kinase activity, but not the PPXYmotifs, promotes phosphorylation of Yki, as
evidenced by blotting with phospho-speciﬁc antisera (Yki-S168P)(Dong et al., 2007) and by Phos-tag gel analysis (Oh and Irvine, 2008). (E) Upper panel shows that FLAG-tagged
Hpo can co-precipitate endogenous Yki; lower panel shows that V5 tagged Yki can co-precipitate endogenous Hpo. GFP control proteins are not visible here because their mobilities
are distinct from Hpo and Yki. (F) Co-precipitation of HpoY591A,(PPXA), Wts, and Yki in S2 cells. Yki-Hpo binding requires the PPXY motif of Hpo, and is not affected by exogenous
Wts; Wts-Hpo binding does not require the Hpo PPXY motif.
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195H. Oh et al. / Developmental Biology 335 (2009) 188–197(Figs. 4C, D). Endogenous localization proﬁles for Hpo and Wts have
not been described, but when epitope-tagged forms of Wts are over-
expressed, they appear slightly enriched apically, but otherwise
broadly distributed throughout the cytoplasm (Cho et al., 2006).
Hence the Wts localization proﬁle is potentially consistent with
widespread Yki interaction.
To quantify the inﬂuence of the WW domains on Yki localization,
Yki:V5 and Yki:V5-WW were expressed in identical locations, in a
stripe of cells along the center of the wing imaginal disc under ptc-
Gal4 control. A slight increase in Yki nuclear localization was detected
(Figs. 4A, B; Mean nuclear/cytoplasmic ratio of 0.26 for Yki:V5-WW
and 0.22 Yki:V5), and the difference was statistically signiﬁcant (P
value=0.013), consistent with the possibility that the WW domains
inﬂuence Yki localization in vivo. The effect was slight, but this might
be explained in part by a simultaneous decrease in binding to nuclear
co-activators that interact with WW domains.
To further investigate the potential inﬂuence of Yki's WW domains
on its localization, we over-expressed Ex, because its localization is
normally so different from Yki's. Over-expression of Ex kills cells
(Blaumueller and Mlodzik, 2000), but this lethality is suppressed by
mutation ofwts (Cho et al., 2006; Hamaratoglu et al., 2006). Indeed, as
wehavenotedpreviously, clones of cells over-expressingExbutmutant
for wts appear very similar to wts mutant clones without Ex over-
expression, both in terms of their size and shape, and the expression of
downstream genes (Cho et al., 2006) (Figs. 4G, H). This differs from the
recent report of Badouel et al (2009), but they appear to have used a
different UAS-ex transgene, which, if it drives higher expression, might
be able to bypass the normal requirement for wts, just as high level
over-expression of Ex in cultured cells can effect a Wts-independent
repression of Yki3SA-Gal4DBD mediated transcription (Fig. 3A).
When the localization of Yki in wtsmutant clones over-expressing
Exwas examined, we found that in addition to the weaker cytoplasmic
and stronger nuclear staining characteristic ofwtsmutant clones (Dong
et al., 2007; Oh and Irvine, 2008), a fraction of Yki now accumulated at
the sub-apicalmembrane,where it overlapped Ex (Figs. 4K, L). A partial
overlap between Ex and Yki at the subapical membrane could also be
detected when the lethality of clones expressing Ex and Hpo was
rescued by expression of Yki:V53SA (Figs. 4E, F).
In the course of doing these experiments we realized that a visible
accumulation and overlap of Yki with Ex could also be observed inwts
mutant clones in which Ex was not over-expressed from UAS
transgenes (Figs. 4I, J). Because Ex is a transcriptional target of Fat-
Hippo signaling, Ex is over-expressed from the endogenous ex locus in
wtsmutant clones (Hamaratoglu et al., 2006)(Figs. 4I, J). Importantly,
this accumulation of Yki with Ex observed in wts clones indicates that
tethering of Yki outside the nucleus at sites of Ex accumulation is not
solely a consequence of over-expression of exogenous Ex, but rather
can be effected by endogenous Ex.
Discussion
The discovery of Yki as an oncogene that is genetically downstream
of wts and a substrate of Wts kinase activity led to a model in whichFig. 4. Yki localization in imaginal cells. Portions of wing discs, panels marked by prime sy
UAS-yki:V5 (A) or UAS-yki:V5-WW (B) under ptc-Gal4. (C, D) ykiB5 mutant clones in the win
clones are shown to emphasize that the staining in wild-type cells is not background, and
section, (D) Shows a horizontal section, because this is a thin section and the discs are not ﬂ
mutant clones. (E, F) Horizontal (E) and vertical (F) sections through a clone co-expressing
of Yki (green/white) co-localizes with Ex (magenta/white) at the sub-apical membrane, i
was detected. (G, H) Wing imaginal discs with MARCM clones (marked by presence of GFP,
also over-express Ex from a UAS-ex transgene. Upregulation of Diap1 (arrows), clone size, a
of Ex (magenta/white) and Yki (green/white) at the sub-apical membrane in wtsX1 mutan
express endogenous Ex due to mutation of wts (Hamaratoglu et al., 2006), clones in K, L als
elevated Ex, endogenous Ex in wild-type cells is not detected. By contrast to the situatio
identiﬁed over-lapping Ex. Examples of this are highlighted by the yellow boxes.Fat-Hippo signaling regulates Yki by phosphorylation (Huang et al.,
2005). However, the results described here, together with the recent
study of Badouel et al (2009), identify an alternate mechanism that
does not involve phosphorylation (Fig. 5). Since they can visibly affect
the sub-cellular localization of Yki3SA in disc cells (Figs. 1, 4)(Oh and
Irvine, 2009), and directly bind to Yki in cultured cell assays (Fig. 2)
(Badouel et al., 2009), the simplest explanation would be that Wts, Ex
and Hpo exclude Yki from the nucleus by acting directly as
cytoplasmic anchoring proteins. Phosphorylation-independent re-
pression is expected to require the WW domains, but analysis of their
importance to Yki repression is complicated by their positive role in
transcriptional activation by Yki (Oh and Irvine, 2009; Zhao et al.,
2009). Indeed, the dual role of the WW domains in both repressing
and activating Yki suggests a model in which positive and negative
factors compete for association with Yki at its WWdomains. Mutation
of theWWdomains did increase Yki nuclear localization, although the
effect was subtle. However, even when the most critical Wts
phosphorylation site on Yki (Ser168) is mutated, Yki localization is
only modestly affected (Oh and Irvine, 2008). Thus Yki localization is
affected not only by its phosphorylation, but also by interaction with
other factors.
The discovery of this alternate Yki repression mechanism raises
the question of its relevance to normal Yki regulation in vivo. The
critical regulatory step in phosphorylation-dependent repression is
the amount of active Wts, which is reﬂected in the phosphorylation
status of Yki. Conversely, the critical regulatory step in phosphory-
lation-independent repression is expected to be the total amount of
Wts, Ex and Hpo relative to Yki. Most published analysis of Yki
regulation, including both loss-of-function and gain-of-function
experiments, in vivo and in cultured cells, have involved manipula-
tions of Fat-Hippo signaling that could potentially affect both of these
mechanisms, and thus haven’t distinguished between them. Indeed,
since they involve the same upstream tumor suppressors, both
phosphorylation-dependent and phosphorylation-independent
mechanisms could normally function in parallel to repress Yki, and
there are observations that support the relevance of both types of
regulation.
The most direct evidence in support of the importance of
phosphorylation-dependent repression is provided by mutation of
Wts phosphorylation sites on Yki. In the context of over-expressed
Yki, the Wts phosphorylation sites are crucial, as UAS-yki:V5
transgenes inserted at identical chromosomal locations have no
phenotype in their wild-type form, but dramatic overgrowth
phenotypes when the Wts phosphorylation sites are mutant (Oh
and Irvine, 2009), and similar results have been reported for YAP and
Yki phosphorylation site mutants using a variety of approaches (Dong
et al., 2007; Hao et al., 2008; Oh and Irvine, 2008; Zhang et al., 2008;
Zhao et al., 2007). Since over-expression of kinase dead Hpo has a
mild dominant negative phenotype, one can also infer that, at least for
Hpo, its role in phosphorylation-dependent repression outweighs its
contribution to phosphorylation-independent repression. In the
context of endogenous yki the evidence is more circumstantial.
Gain-of-function alleles of yki with mutations surrounding thembols show individual channels of immunoﬂuorescent staining. (A, B) Expression of
g imaginal disc, marked by absence of Yki (green) and stained for Ex (magenta). yki
that in wild-type Yki co-localization with Ex was not discernible. (C) Shows a vertical
at Ex staining is in focus in only part of the image; Ex is also down-regulated within yki
Ex, Hpo and Yki:V53SA; (AyGal4; UAS-yki:V5 UAS-hpo[dMst.3]/ UAS-ex[ex-3]) a fraction
n the absence of Ex over-expression no speciﬁc accumulation of Yki at the membrane
green) of cells mutant for wtsX1 and stained for expression of Diap1 (red). Clones in H
nd clone shape are similar in the presence and absence of exogenous Ex. (I–L) Overlap
t clones. I, K show horizontal sections, J, L show vertical sections. Clones in I, J over-
o over-express Ex from a UAS-ex transgene; at the confocal settings used to detect this
n in wild-type, where Ex levels are elevated, a distinct accumulation of Yki could be
Fig. 5.Model of Yki regulation. (A) In the Yki “off” state, Wts is active, and levels of Wts
and Ex are high (thick outline). Active Warts phosphorylates Yki, which inhibits Yki by
promoting its association with 14-3-3 proteins in the cytoplasm, thereby excluding it
from the nucleus. In addition, Wts and Ex can directly bind Yki to exclude it from the
nucleus. (B) In the Yki “on” state, Wts is inactive, and levels of Wts and/or Ex are lower
(dashed outline). Components of the Hippo kinase cassette are unphosphorylated, and
interactions between them are reduced. Yki is not phosphorylated, and enters the
nucleus where it complexes with Sd to promote the transcription of downstream
target genes.
196 H. Oh et al. / Developmental Biology 335 (2009) 188–197phosphorylation site at Ser168 have been identiﬁed (Zhao et al.,
2007). Their phenotypes are quite mild, but it is possible that they do
not completely block phosphorylation and 14-3-3 binding at this site.
In further support of the importance of phosphorylation-dependent
repression, we note that both Ex and Fat have been reported to
inﬂuenceWts activity in cultured cells (Hamaratoglu et al., 2006; Silva
et al., 2006; Willecke et al., 2006), and that Ex and Fat also both
inﬂuence Yki phosphorylation in vivo (Oh and Irvine, 2008).
The clearest evidence in support of phosphorylation-independent
repression is the observation that Wts, Ex and Hpo can repress the
activity of Yki3SA, both in vivo and in cultured cell assays (Figs. 1,3).
This repression was readily detected when Wts, Ex and Hpo wereexpressed in combination at the same levels as Yki (i.e., under the
same promoter), or when a single one of these proteins was expressed
at higher levels. Although the absolute levels of Yki versus these
upstream tumor suppressors in vivo are not known, they can vary
substantially. Ex is subject to negative feedback regulation in Fat-
Hippo signaling, as elevated transcription of ex is a consequence of Yki
activation (Hamaratoglu et al., 2006). Indeed, under the elevated Ex
levels that exist in wts mutants, a fraction of Yki became visibly co-
localized with Ex, suggesting that direct binding between Ex and Yki
at least contributes to negative feedback regulation in Fat-Hippo
signaling. Conversely, mutation or inactivation of Fat can decrease
levels of Ex at the membrane, whichmight decrease phosphorylation-
independent repression of Yki by Ex. Fat also has a strong effect on the
total amount of Wts protein in cells (Cho et al., 2006). Moreover, the
total amount ofWts is critical for the normal regulation of Yki, as over-
expression of Wts can suppress fat, ex or dco3 mutations (Feng and
Irvine, 2007, 2009). Finally, we note that a marked elevation in total
YAP levels, as opposed to a simple change in the YAP phosphorylation
state, has been observed in many solid tumors (Steinhardt et al.,
2008). Taken together, these observations suggest that phosphoryla-
tion-independent repression could be important in some contexts in
vivo. Moreover, our observations clearly establish that phosphoryla-
tion-independent repression can occur when this pathway is
experimentally manipulated, and hence must be taken into consid-
eration, both in evaluating past results and designing future
experiments.
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